Copyright Reports & Markets. All rights reserved.

Global MHC-peptide Complexes Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global MHC-peptide Complexes Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Peptide MHC Class I Complexes
    • 1.3.3 Peptide MHC Class II Complexes
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global MHC-peptide Complexes Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Scientific Research
    • 1.4.3 Pharmaceuticals
  • 1.5 Global MHC-peptide Complexes Market Size & Forecast
    • 1.5.1 Global MHC-peptide Complexes Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global MHC-peptide Complexes Sales Quantity (2020-2031)
    • 1.5.3 Global MHC-peptide Complexes Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Creative Biolabs
    • 2.1.1 Creative Biolabs Details
    • 2.1.2 Creative Biolabs Major Business
    • 2.1.3 Creative Biolabs MHC-peptide Complexes Product and Services
    • 2.1.4 Creative Biolabs MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Creative Biolabs Recent Developments/Updates
  • 2.2 Creative Peptides
    • 2.2.1 Creative Peptides Details
    • 2.2.2 Creative Peptides Major Business
    • 2.2.3 Creative Peptides MHC-peptide Complexes Product and Services
    • 2.2.4 Creative Peptides MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Creative Peptides Recent Developments/Updates
  • 2.3 Creative BioMart
    • 2.3.1 Creative BioMart Details
    • 2.3.2 Creative BioMart Major Business
    • 2.3.3 Creative BioMart MHC-peptide Complexes Product and Services
    • 2.3.4 Creative BioMart MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Creative BioMart Recent Developments/Updates
  • 2.4 Revvity (BioLegend)
    • 2.4.1 Revvity (BioLegend) Details
    • 2.4.2 Revvity (BioLegend) Major Business
    • 2.4.3 Revvity (BioLegend) MHC-peptide Complexes Product and Services
    • 2.4.4 Revvity (BioLegend) MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Revvity (BioLegend) Recent Developments/Updates
  • 2.5 ImmunAware
    • 2.5.1 ImmunAware Details
    • 2.5.2 ImmunAware Major Business
    • 2.5.3 ImmunAware MHC-peptide Complexes Product and Services
    • 2.5.4 ImmunAware MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 ImmunAware Recent Developments/Updates
  • 2.6 ACROBiosystems
    • 2.6.1 ACROBiosystems Details
    • 2.6.2 ACROBiosystems Major Business
    • 2.6.3 ACROBiosystems MHC-peptide Complexes Product and Services
    • 2.6.4 ACROBiosystems MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 ACROBiosystems Recent Developments/Updates
  • 2.7 MBL International
    • 2.7.1 MBL International Details
    • 2.7.2 MBL International Major Business
    • 2.7.3 MBL International MHC-peptide Complexes Product and Services
    • 2.7.4 MBL International MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 MBL International Recent Developments/Updates
  • 2.8 ProImmune Ltd
    • 2.8.1 ProImmune Ltd Details
    • 2.8.2 ProImmune Ltd Major Business
    • 2.8.3 ProImmune Ltd MHC-peptide Complexes Product and Services
    • 2.8.4 ProImmune Ltd MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 ProImmune Ltd Recent Developments/Updates
  • 2.9 KACTUS
    • 2.9.1 KACTUS Details
    • 2.9.2 KACTUS Major Business
    • 2.9.3 KACTUS MHC-peptide Complexes Product and Services
    • 2.9.4 KACTUS MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 KACTUS Recent Developments/Updates
  • 2.10 AtaGenix
    • 2.10.1 AtaGenix Details
    • 2.10.2 AtaGenix Major Business
    • 2.10.3 AtaGenix MHC-peptide Complexes Product and Services
    • 2.10.4 AtaGenix MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 AtaGenix Recent Developments/Updates
  • 2.11 Yeasen
    • 2.11.1 Yeasen Details
    • 2.11.2 Yeasen Major Business
    • 2.11.3 Yeasen MHC-peptide Complexes Product and Services
    • 2.11.4 Yeasen MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Yeasen Recent Developments/Updates
  • 2.12 Shanghai Proteinscript
    • 2.12.1 Shanghai Proteinscript Details
    • 2.12.2 Shanghai Proteinscript Major Business
    • 2.12.3 Shanghai Proteinscript MHC-peptide Complexes Product and Services
    • 2.12.4 Shanghai Proteinscript MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Shanghai Proteinscript Recent Developments/Updates
  • 2.13 HelixGen
    • 2.13.1 HelixGen Details
    • 2.13.2 HelixGen Major Business
    • 2.13.3 HelixGen MHC-peptide Complexes Product and Services
    • 2.13.4 HelixGen MHC-peptide Complexes Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 HelixGen Recent Developments/Updates

3 Competitive Environment: MHC-peptide Complexes by Manufacturer

  • 3.1 Global MHC-peptide Complexes Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global MHC-peptide Complexes Revenue by Manufacturer (2020-2025)
  • 3.3 Global MHC-peptide Complexes Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of MHC-peptide Complexes by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 MHC-peptide Complexes Manufacturer Market Share in 2024
    • 3.4.3 Top 6 MHC-peptide Complexes Manufacturer Market Share in 2024
  • 3.5 MHC-peptide Complexes Market: Overall Company Footprint Analysis
    • 3.5.1 MHC-peptide Complexes Market: Region Footprint
    • 3.5.2 MHC-peptide Complexes Market: Company Product Type Footprint
    • 3.5.3 MHC-peptide Complexes Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global MHC-peptide Complexes Market Size by Region
    • 4.1.1 Global MHC-peptide Complexes Sales Quantity by Region (2020-2031)
    • 4.1.2 Global MHC-peptide Complexes Consumption Value by Region (2020-2031)
    • 4.1.3 Global MHC-peptide Complexes Average Price by Region (2020-2031)
  • 4.2 North America MHC-peptide Complexes Consumption Value (2020-2031)
  • 4.3 Europe MHC-peptide Complexes Consumption Value (2020-2031)
  • 4.4 Asia-Pacific MHC-peptide Complexes Consumption Value (2020-2031)
  • 4.5 South America MHC-peptide Complexes Consumption Value (2020-2031)
  • 4.6 Middle East & Africa MHC-peptide Complexes Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 5.2 Global MHC-peptide Complexes Consumption Value by Type (2020-2031)
  • 5.3 Global MHC-peptide Complexes Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 6.2 Global MHC-peptide Complexes Consumption Value by Application (2020-2031)
  • 6.3 Global MHC-peptide Complexes Average Price by Application (2020-2031)

7 North America

  • 7.1 North America MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 7.2 North America MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 7.3 North America MHC-peptide Complexes Market Size by Country
    • 7.3.1 North America MHC-peptide Complexes Sales Quantity by Country (2020-2031)
    • 7.3.2 North America MHC-peptide Complexes Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 8.2 Europe MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 8.3 Europe MHC-peptide Complexes Market Size by Country
    • 8.3.1 Europe MHC-peptide Complexes Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe MHC-peptide Complexes Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific MHC-peptide Complexes Market Size by Region
    • 9.3.1 Asia-Pacific MHC-peptide Complexes Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific MHC-peptide Complexes Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 10.2 South America MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 10.3 South America MHC-peptide Complexes Market Size by Country
    • 10.3.1 South America MHC-peptide Complexes Sales Quantity by Country (2020-2031)
    • 10.3.2 South America MHC-peptide Complexes Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa MHC-peptide Complexes Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa MHC-peptide Complexes Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa MHC-peptide Complexes Market Size by Country
    • 11.3.1 Middle East & Africa MHC-peptide Complexes Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa MHC-peptide Complexes Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 MHC-peptide Complexes Market Drivers
  • 12.2 MHC-peptide Complexes Market Restraints
  • 12.3 MHC-peptide Complexes Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of MHC-peptide Complexes and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of MHC-peptide Complexes
  • 13.3 MHC-peptide Complexes Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 MHC-peptide Complexes Typical Distributors
  • 14.3 MHC-peptide Complexes Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global MHC-peptide Complexes market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    MHC binds to peptides derived from degraded intracellular antigens to form MHC-peptide complexes, which are then transported to the cell surface. These MHC complexes are recognized by corresponding T cell receptors (TCR) to initiate an immune response. In humans, the MHC complexes involved in antigen presentation are mainly MHC class I and MHC class II. MHC class I, when bound to antigenic peptides, is recognized by CD8+ T cells, while MHC class II, when bound to antigenic peptides, is recognized by CD4+ T cells. Targeting MHC complexes can achieve the killing of tumor cells.
    This report is a detailed and comprehensive analysis for global MHC-peptide Complexes market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global MHC-peptide Complexes market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global MHC-peptide Complexes market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global MHC-peptide Complexes market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
    Global MHC-peptide Complexes market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for MHC-peptide Complexes
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global MHC-peptide Complexes market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Creative Peptides, Creative BioMart, Revvity (BioLegend), ImmunAware, ACROBiosystems, MBL International, ProImmune Ltd, KACTUS, AtaGenix, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    MHC-peptide Complexes market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Peptide MHC Class I Complexes
    Peptide MHC Class II Complexes
    Market segment by Application
    Scientific Research
    Pharmaceuticals
    Major players covered
    Creative Biolabs
    Creative Peptides
    Creative BioMart
    Revvity (BioLegend)
    ImmunAware
    ACROBiosystems
    MBL International
    ProImmune Ltd
    KACTUS
    AtaGenix
    Yeasen
    Shanghai Proteinscript
    HelixGen
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe MHC-peptide Complexes product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of MHC-peptide Complexes, with price, sales quantity, revenue, and global market share of MHC-peptide Complexes from 2020 to 2025.
    Chapter 3, the MHC-peptide Complexes competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the MHC-peptide Complexes breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and MHC-peptide Complexes market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of MHC-peptide Complexes.
    Chapter 14 and 15, to describe MHC-peptide Complexes sales channel, distributors, customers, research findings and conclusion.

    Buy now